Cargando…

A clinical study of canine collagen type III glomerulopathy

BACKGROUND: Collagen type III glomerulopathy (Col3GP), also known as collagenofibrotic glomerulonephropathy, is a rare renal disease with unknown pathogenesis that occurs in animals and humans. We recently described a naturally occurring canine autosomal recessive model of Col3GP, and the aim of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rørtveit, Runa, Eggertsdóttir, Anna Vigdís, Thomassen, Ragnar, Lingaas, Frode, Jansen, Johan Høgset
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826668/
https://www.ncbi.nlm.nih.gov/pubmed/24156559
http://dx.doi.org/10.1186/1746-6148-9-218
_version_ 1782290943087476736
author Rørtveit, Runa
Eggertsdóttir, Anna Vigdís
Thomassen, Ragnar
Lingaas, Frode
Jansen, Johan Høgset
author_facet Rørtveit, Runa
Eggertsdóttir, Anna Vigdís
Thomassen, Ragnar
Lingaas, Frode
Jansen, Johan Høgset
author_sort Rørtveit, Runa
collection PubMed
description BACKGROUND: Collagen type III glomerulopathy (Col3GP), also known as collagenofibrotic glomerulonephropathy, is a rare renal disease with unknown pathogenesis that occurs in animals and humans. We recently described a naturally occurring canine autosomal recessive model of Col3GP, and the aim of the present work was to study the clinical features of canine Col3GP and compare with the human phenotype. In humans two different clinical syndromes with different age at onset (child- or adulthood) have been observed. In children a more aggressive course with familial occurrence is described, characterized by progressively increasing proteinuria, nephrotic syndrome, hypertension and chronic renal failure. A markedly increased serum level of the aminoterminal propeptide of type III procollagen (PIIINP) is considered a useful marker for the disease. Since Col3GP and concurrent hypocomplementemia have been observed in humans, we also aimed to investigate if hypocomplementemia was present in Col3GP affected dogs. A litter consisting of seven puppies, four Col3GP affected and three healthy unaffected, was observed from the day of birth until the affected puppies developed a mild or moderate renal azotemia. RESULTS: During the period of observation growth retardation, increasing blood pressure, progressive proteinuria, azotemia, hypoalbuminemia, hypercholesterolemia and increased serum PIIINP were observed in all the affected dogs. Hypocomplementemia was not detected. Affected dogs were euthanized between 109 and 144 days of age, and pathological examinations revealed ascites and massive glomerular accumulations of collagen type III, consistent with Col3GP. CONCLUSIONS: Dogs with Col3GP develop juvenile chronic renal failure, preceded by nephrotic syndrome, elevated serum PIIINP and hypertension, thus have similar clinical features as the juvenile Col3GP in humans. Further studies of this naturally occurring canine phenotype may provide more information on the pathogenesis and genetics of Col3GP in both animals and humans.
format Online
Article
Text
id pubmed-3826668
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38266682013-11-14 A clinical study of canine collagen type III glomerulopathy Rørtveit, Runa Eggertsdóttir, Anna Vigdís Thomassen, Ragnar Lingaas, Frode Jansen, Johan Høgset BMC Vet Res Research Article BACKGROUND: Collagen type III glomerulopathy (Col3GP), also known as collagenofibrotic glomerulonephropathy, is a rare renal disease with unknown pathogenesis that occurs in animals and humans. We recently described a naturally occurring canine autosomal recessive model of Col3GP, and the aim of the present work was to study the clinical features of canine Col3GP and compare with the human phenotype. In humans two different clinical syndromes with different age at onset (child- or adulthood) have been observed. In children a more aggressive course with familial occurrence is described, characterized by progressively increasing proteinuria, nephrotic syndrome, hypertension and chronic renal failure. A markedly increased serum level of the aminoterminal propeptide of type III procollagen (PIIINP) is considered a useful marker for the disease. Since Col3GP and concurrent hypocomplementemia have been observed in humans, we also aimed to investigate if hypocomplementemia was present in Col3GP affected dogs. A litter consisting of seven puppies, four Col3GP affected and three healthy unaffected, was observed from the day of birth until the affected puppies developed a mild or moderate renal azotemia. RESULTS: During the period of observation growth retardation, increasing blood pressure, progressive proteinuria, azotemia, hypoalbuminemia, hypercholesterolemia and increased serum PIIINP were observed in all the affected dogs. Hypocomplementemia was not detected. Affected dogs were euthanized between 109 and 144 days of age, and pathological examinations revealed ascites and massive glomerular accumulations of collagen type III, consistent with Col3GP. CONCLUSIONS: Dogs with Col3GP develop juvenile chronic renal failure, preceded by nephrotic syndrome, elevated serum PIIINP and hypertension, thus have similar clinical features as the juvenile Col3GP in humans. Further studies of this naturally occurring canine phenotype may provide more information on the pathogenesis and genetics of Col3GP in both animals and humans. BioMed Central 2013-10-24 /pmc/articles/PMC3826668/ /pubmed/24156559 http://dx.doi.org/10.1186/1746-6148-9-218 Text en Copyright © 2013 Rørtveit et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Rørtveit, Runa
Eggertsdóttir, Anna Vigdís
Thomassen, Ragnar
Lingaas, Frode
Jansen, Johan Høgset
A clinical study of canine collagen type III glomerulopathy
title A clinical study of canine collagen type III glomerulopathy
title_full A clinical study of canine collagen type III glomerulopathy
title_fullStr A clinical study of canine collagen type III glomerulopathy
title_full_unstemmed A clinical study of canine collagen type III glomerulopathy
title_short A clinical study of canine collagen type III glomerulopathy
title_sort clinical study of canine collagen type iii glomerulopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826668/
https://www.ncbi.nlm.nih.gov/pubmed/24156559
http://dx.doi.org/10.1186/1746-6148-9-218
work_keys_str_mv AT rørtveitruna aclinicalstudyofcaninecollagentypeiiiglomerulopathy
AT eggertsdottirannavigdis aclinicalstudyofcaninecollagentypeiiiglomerulopathy
AT thomassenragnar aclinicalstudyofcaninecollagentypeiiiglomerulopathy
AT lingaasfrode aclinicalstudyofcaninecollagentypeiiiglomerulopathy
AT jansenjohanhøgset aclinicalstudyofcaninecollagentypeiiiglomerulopathy
AT rørtveitruna clinicalstudyofcaninecollagentypeiiiglomerulopathy
AT eggertsdottirannavigdis clinicalstudyofcaninecollagentypeiiiglomerulopathy
AT thomassenragnar clinicalstudyofcaninecollagentypeiiiglomerulopathy
AT lingaasfrode clinicalstudyofcaninecollagentypeiiiglomerulopathy
AT jansenjohanhøgset clinicalstudyofcaninecollagentypeiiiglomerulopathy